Browsing by Author Margiotta-Casaluci, L
Showing results 1 to 20 of 23
next >
Issue Date | Title | Author(s) |
---|---|---|
2021 | Advancing the mechanistic understanding of the toxicological effects of non-steroidal anti-inflammatory drugs (NSAIDs) using integrated in silico and in vivo approaches | Marmon, Philip Konstantin Alexander |
28-Feb-2018 | Adverse outcome pathway networks I: Development and applications | Knapen, D; Angrish, MM; Fortin, MC; Katsiadaki, I; Leonard, M; Margiotta-Casaluci, L; Munn, S; O'Brien, JM; Pollesch, N; Smith, LC; Zhang, X; Villeneuve, DL |
28-Feb-2018 | Adverse outcome pathway networks II: Network analytics | Villeneuve, DL; Angrish, MM; Fortin, MC; Katsiadaki, I; Leonard, M; Margiotta-Casaluci, L; Munn, S; O'Brien, JM; Pollesch, NL; Smith, LC; Zhang, X; Knapen, D |
2016 | Anti-anxiety drugs and fish behavior: Establishing the link between internal concentrations of oxazepam and behavioral effects | Huerta, B; Margiotta-Casaluci, L; Rodríguez-Mozaz, S; Scholze, M; Winter, MJ; Barceló, D; Sumpter, JP |
11-Apr-2022 | COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop | Clerbaux, L-A; Amigó, N; Amorim, MJ; Bal-Price, A; Batista Leite, S; Beronius, A; Bezemer, GFG; Bostroem, A-C; Carusi, A; Coecke, S; Concha, R; Daskalopoulos, EP; Debernardi, F; Edrosa, E; Edwards, SW; Filipovska, J; Garcia-Reyero, N; Gavins, FNE; Halappanavar, S; Hargreaves, AJ; Hogberg, HT; Huynh, MT; Jacobson, D; Josephs-Spaulding, J; Kim, YJ; Kong, HJ; Krebs, CE; Lam, A; Landesmann, B; Layton, AR; Lee, YO; Macmillan, DS; Mantovani, A; Margiotta-Casaluci, L; Martens, M; Masereeuw, R; Mayasich, SA; Mei, LM; Mortensen, H; Munoz Pineiro, A; Nymark, P; Ohayon, E; Ojasi, JM; Paini, A; Parissis, N; Parvatam, S; Pistollato, F; Sachana, M; Sørli, JB; Sullivan, KM; Sund, J; Tanabe, S; Tsaioun, K; Vinken, M; Viviani, L; Waspe, J; Willett, C; Wittwehr, C |
3-May-2022 | Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use | Sumpter, JP; Margiotta-Casaluci, L |
2016 | Erratum: Internal exposure dynamics drive the Adverse Outcome Pathways of synthetic glucocorticoids in fish | Margiotta-Casaluci, L; Owen, SF; Huerta, B; Rodriguez-Mozaz, S; Kugathas, S; Barcelo, D; Rand-Weaver, M; Sumpter, JP |
2015 | From single chemicals to mixtures-Reproductive effects of levonorgestrel and ethinylestradiol on the fathead minnow. | Runnalls, TJ; Beresford, N; Kugathas, S; Margiotta-Casaluci, L; Scholze, M; Scott, AP; Sumpter, JP |
14-May-2020 | The goliath project: Towards an internationally harmonised approach for testing metabolism disrupting compounds | Legler, J; Zalko, D; Jourdan, F; Jacobs, M; Fromenty, B; Balaguer, P; Bourguet, W; Kos, VM; Nadal, A; Beausoleil, C; Cristobal, S; Remy, S; Ermler, S; Margiotta-Casaluci, L; Griffin, JL; Blumberg, B; Chesné, C; Hoffmann, S; Andersson, PL; Kamstra, JH |
30-Jul-2019 | Immunoassays are not immune to errors: Examples from two studies of steroid output from freshwater trout farms | Ellis, T; Margiotta-Casaluci, L; Pottinger, TG; Morris, S; Reese, RA; Sumpter, JP; Scott, AP |
2016 | Internal exposure dynamics drive the Adverse Outcome Pathways of synthetic glucocorticoids in fish | Margiotta-Casaluci, L; Owen, SF; Huerta, B; Rodríguez-Mozaz, S; Kugathas, S; Barceló, D; Rand-Weaver, M; Sumpter, JP |
23-Apr-2020 | New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop | Mahony, C; Ashton, RS; Birk, B; Boobis, AR; Cull, T; Daston, GP; Ewart, L; Knudsen, TB; Manou, I; Maurer-Stroh, S; Margiotta-Casaluci, L; Müller, BP; Nordlund, P; Roberts, RA; Steger-Hartmann, T; Vandenbossche, E; Viant, MR; Vinken, M; Whelan, M; Zvonimir, Z; Cronin, MTD |
2014 | A new role for carbonic anhydrase 2 in the response of fish to copper and osmotic stress: Implications for multi-stressor studies | De Polo, A; Margiotta-Casaluci, L; Lockyer, AE; Scrimshaw, MD |
28-May-2019 | Pharmacology beyond the patient – The environmental risks of human drugs | Gunnarsson, L; Snape, JR; Verbruggen, B; Owen, SF; Kristiansson, E; Margiotta-Casaluci, L; Österlund, T; Hutchinson, K; Leverett, D; Marks, B; Tyler, CR |
3-Nov-2020 | Pharmacology-informed prediction of the risk posed to fish by mixtures of non-steroidal anti-inflammatory drugs (NSAIDs) in the environment | Marmon, P; Owen, SF; Margiotta-Casaluci, L |
2011 | Preliminary data on the influence of rearing temperature on the growth and reproductive status of fathead minnows Pimephales promelas | Brian, JV; Beresford, NA; Margiotta-Casaluci, L; Sumpter, JP |
6-Feb-2019 | Protecting the environment from psychoactive drugs: Problems for regulators illustrated by the possible effects of tramadol on fish behaviour | Tanoue, R; Margiotta-Casaluci, L; Huerta, B; Runnalls, TJ; Eguchi, A; Nomiyama, K; Kunisue, T; Tanabe, S; Sumpter, JP |
2014 | Quantitative cross-species extrapolation between humans and fish: The case of the anti-depressant fluoxetine | Margiotta-Casaluci, L; Owen, SF; Cumming, RI; De Polo, A; Winter, MJ; Panter, GH; Rand-Weaver, M; Sumpter, JP |
2013 | The read-across hypothesis and environmental risk assessment of pharmaceuticals | Rand-Weaver, M; Margiotta-Casaluci, L; Patel, A; Panter, GH; Owen, SF; Sumpter, JP |
2019 | Testing the translational power of the zebrafish: an inter-species analysis of responses to cardiovascular drugs | Margiotta-Casaluci, L; Owen, S; Rand-Weaver, M; Winter, M |